# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Truist Securities analyst David Macdonald maintains Elevance Health (NYSE:ELV) with a Buy and raises the price target from $...
Cantor Fitzgerald analyst Sarah James reiterates Elevance Health (NYSE:ELV) with a Overweight and maintains $600 price target.
Morgan Stanley initiates coverage on Elevance Health with an Overweight rating and a $643 price target. Elevance Health's d...
Morgan Stanley analyst Erin Wright initiates coverage on Elevance Health (NYSE:ELV) with a Overweight rating and announces P...